Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 13 OTHER 11 OTHER_GOV 1 NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Estrogen Receptor Positive Breast Cancer 1

Interventions

Tamoxifen 10 Capecitabine 10 Trastuzumab 9 Docetaxel 9 pyrotinib 7 Exercise 7 Control Groups 7 Vinorelbine 6 Paclitaxel 6 Letrozole 6 Gemcitabine 6 Cyclophosphamide 6 Carboplatin 6 exemestane 5 Indocyanine Green 5 Anastrozole 5 pertuzumab 4 dalpiciclib 4 Injections 4 Fulvestrant 4 Doxorubicin 4 Tablets 3 Surgical Procedures, Operative 3 Standard of Care 3 Radiotherapy 3 Radiation 3 Mammography 3 Epirubicin 3 Drug Therapy 3 Cisplatin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × capivasertib × Breast × Clear all

NCT01992952 2025-11-26

FAKTION

Velindre NHS Trust

Phase 1/2 Active not recruiting

Estrogen Receptor Positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡